Srx Health Solutions Inc. (SRXH) Stock Falls on Q1 2026 Earnings

By: Quiver EarningsTracker

Posted: 13 hours ago / Feb. 13, 2026 10:47 p.m. UTC

SRXH

Srx Health Solutions Inc. (SRXH) reported first-quarter 2026 results marked by a steep revenue decline and wider losses, with the company posting total revenues of $2.81 million and an operating loss that widened versus the prior year.

Key income statement items:

Total revenue: $2.81 million (down 60.8% year-over-year).

Gross profit: $1.05 million (down 55.8% year-over-year).

Cost of sales: $1.75 million (down 63.3% year-over-year).

Operating loss: -$3.79 million (change of +248.4% year-over-year).

Net loss attributable to common shareholders: -$8.61 million (change of +793.6% year-over-year); diluted EPS: -$0.26 (down 29.7% year-over-year).

Cash flow and balance sheet highlights:

Cash from operating activities: -$2.92 million (down 860.9% year-over-year).

Purchases of property, plant and equipment: $198,000 (change of -2928.6% year-over-year).

Cash and cash equivalents: $13.06 million (up 1048.6% year-over-year).

Total liabilities: $23.53 million (up 221.3% year-over-year).

Market reaction and takeaway:

Shares of SRXH fell by 11.95% since market close.

The quarter shows sharp revenue contraction and rising liabilities alongside a cash position that increased materially.

Note: This financials data is sourced from a third-party provider and has not been independently verified by Quiver.

Srx Health Solutions Inc. Hedge Fund Activity

We have seen 12 institutional investors add shares of Srx Health Solutions Inc. stock to their portfolio, and 10 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

VANGUARD GROUP INC added 124,006 shares (+79.1%) to their portfolio in Q4 2025, for an estimated $28,298
UBS GROUP AG added 42,639 shares (+10767.4%) to their portfolio in Q4 2025, for an estimated $9,730
GEODE CAPITAL MANAGEMENT, LLC added 42,378 shares (+58.6%) to their portfolio in Q4 2025, for an estimated $9,670
ALTIUM CAPITAL MANAGEMENT LLC removed 38,984 shares (-100.0%) from their portfolio in Q3 2025, for an estimated $12,357
MORGAN STANLEY added 34,000 shares (+inf%) to their portfolio in Q4 2025, for an estimated $7,758
HRT FINANCIAL LP removed 28,782 shares (-100.0%) from their portfolio in Q3 2025, for an estimated $9,123
MAREX GROUP PLC added 25,000 shares (+inf%) to their portfolio in Q4 2025, for an estimated $5,705

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.